Document Detail

Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension.
MedLine Citation:
PMID:  20368505     Owner:  NLM     Status:  MEDLINE    
Aldosterone receptor blockade and thiazide therapy effectively lower blood pressure in geriatric hypertension. Their impact on sympathetic nervous system function has not been evaluated. In a double-blind, randomized study, 36 patients with stage 1 hypertension underwent 6 months of therapy with either aldosterone receptor blockade (spironolactone, n=19; 68+/-1 years) or hydrochlorothiazide (n=17; 68+/-2 years). Arterial blood pressure, [(3)H]-norepinephrine (NE) kinetics (extravascular NE release rate), and alpha-adrenergic responsiveness (forearm vasoconstriction to graded intrabrachial artery NE infusions) were evaluated at baseline, after a 4-week antihypertensive medication withdrawal, and after spironolactone or hydrochlorothiazide treatment. Arterial blood pressure decreased significantly with both spironolactone (160+/-3 to 134+/-2 mm Hg; 77+/-2 to 68+/-2 mm Hg) and hydrochlorothiazide (161+/-4 to 145+/-4 mm Hg; 78+/-2 to 73+/-2 mm Hg) treatment. Sympathetic nervous system activity was significantly reduced after spironolactone (plasma NE: 378+/-40 to 335+/-20 pg/mL, P=0.04; [(3)H]-NE release rate: 2.74+/-0.3 to 1.97+/-0.2 microg/min per meter squared, P=0.04) but not hydrochlorothiazide (plasma NE: 368+/-25 to 349+/-23 pg/mL, P=0.47; [(3)H]-NE release rate: 2.63+/-0.4 to 2.11+/-0.2 mg/min per meter squared, P=0.21). alpha-Adrenergic responsiveness was unchanged with either drug treatment. These findings demonstrate a beneficial effect of aldosterone receptor blockade on reducing sympathetic nervous system activity and blood pressure in hypertensive older patients.
D Walter Wray; Mark A Supiano
Related Documents :
14981055 - Impaired 11-beta hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in h...
23549365 - Pressure-sensitive paint measurements of transient shock phenomena.
1330385 - Plasma 19-hydroxy-androstenedione (19-oh-a) in essential hypertension.
23214685 - Energy partition at the collapse of spherical cavitation bubbles.
10549575 - Effect of ursodeoxycholic acid on ischemia/reperfusion injury in isolated rat heart.
23676615 - Visit-to-visit variability of blood pressure: current knowledge and future research dir...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2010-04-05
Journal Detail:
Title:  Hypertension     Volume:  55     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-15     Completed Date:  2010-05-28     Revised Date:  2014-09-08    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1217-23     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone / blood
Blood Pressure / drug effects*
Body Composition
Catecholamines / blood
Diuretics / therapeutic use
Heart Rate / drug effects
Hydrochlorothiazide / therapeutic use*
Hypertension / blood,  drug therapy,  physiopathology*
Lipoproteins, HDL / blood
Lipoproteins, LDL / blood
Middle Aged
Mineralocorticoid Receptor Antagonists* / therapeutic use*
Norepinephrine / blood
Patient Selection
Spironolactone / therapeutic use*
Sympathetic Nervous System / drug effects,  physiopathology*
Grant Support
K07 AG 28403/AG/NIA NIH HHS; K07 AG028403/AG/NIA NIH HHS; K24 AG000924/AG/NIA NIH HHS; M01-RR00042/RR/NCRR NIH HHS
Reg. No./Substance:
0/Catecholamines; 0/Diuretics; 0/Lipoproteins, HDL; 0/Lipoproteins, LDL; 0/Mineralocorticoid Receptor Antagonists; 0J48LPH2TH/Hydrochlorothiazide; 27O7W4T232/Spironolactone; 4964P6T9RB/Aldosterone; X4W3ENH1CV/Norepinephrine
Comment In:
Hypertension. 2010 May;55(5):1090-1   [PMID:  20368501 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the r...
Next Document:  Left Atrial Volume Combined With Atrial Pump Function Identifies Hypertensive Patients With a Histor...